PMI’s Pulse of the Profession research found that 52 percent of projects experience scope creep. That number gets cited constantly in operations reviews and delivery debriefs. It drives change control processes, SOW governance frameworks, and formal amendment procedures. Organizations build entire approval workflows to manage it.
They are solving the right problem at the wrong end of the deal.
Scope creep in the traditional sense is a delivery problem. The engagement is underway. The buyer wants more work done. The price does not move. The smart seller issues a Change Order or writes a new SOW and the economics are protected. That process exists for a reason and it works.
The problem that costs more is upstream. It happens before delivery begins. Before the SOW is signed. At the moment the deal is almost closed.
That is where Price Pressure Play #16 operates. And most sellers never see it coming.
IS YOUR PORTCO STALLED?
Not plateaued. Not slow. Stalled. There is a difference, and if you are living it right now, you already know which one it is.
Most operators can identify the symptom. Revenue has stopped moving. Pipeline looks active but nothing is closing. The team is working but the number is not. What they cannot identify is the structural reason, and that is the conversation worth having.
If your portfolio company has stalled, I will tell you why in 30 minutes. No prep required on your end. I use a proprietary diagnostic framework built across 15+ scaling engagements to identify the growth ceiling fast.
Scope is currency. That principle applies downstream during delivery. It applies with even more force upstream, before the engagement starts, when the precedent for the entire relationship is being set.
The buyer who arrives at pre-close with a scope reduction request is not concerned about delivery. They are concerned about price. The reduction is the instrument. The price is the objective.
Recognize the Setup First: The Scope Minimizer
Full-value conversations have occurred. The buyer has agreed the complete offering is what they need. Then, after commercial conversations begin, a scope reduction surfaces. It sounds reasonable. They are “adjusting expectations.” They “probably don’t need all of that.”
Watch for these three tells: the scope reduction arrives after pricing is on the table, the proposed reduction does not proportionally reduce your delivery cost, and the buyer remains focused on the total investment figure rather than the adjusted scope.
The ratio exposes it. If scope drops 20 percent but the desired price drops 35 percent, this is not a scope conversation. It is a pricing conversation wearing a scope conversation as cover.
The math behind it is exact. Unmanaged scope reduction without equivalent margin protection produces deals that close at 14 percent below original investment while maintaining 80 to 90 percent of the original delivery cost. The seller does nearly the same work for significantly less money.
Downstream, that is a margin problem. Upstream, before delivery begins, it is a precedent problem. The client who learns pre-close that scope is negotiable without a proportional tradeoff will test that same assumption throughout the engagement. The scope creep that shows up in delivery reviews was often seeded in the pre-close conversation.
Your Move: The Scope Trade
Step 1: “I can absolutely work with you on the investment structure. Here is how I think about it.”
Step 2: “If we remove [specific deliverable], the investment adjusts to $[reduced price]. If we remove [deliverables A and B], it comes to $[further reduced]. Each adjustment is proportional. I want to make sure we are being precise about the tradeoff. Which structure delivers what you need at an investment level that works?”
Come prepared with pre-built scope tiers and corresponding investment levels before the meeting. Never reduce price without identifying exactly what scope is being removed. Make the tradeoff explicit and visible.
Why This Works
The Scope Trade converts a price conversation into a genuine business decision. The buyer must now choose between scope tiers, not negotiate a discount. That is the structural shift.
And the downstream effect matters as much as the upstream win. When a buyer encounters the Scope Trade pre-close, they learn something about how you operate. Scope is currency here. It is traded, not given. That understanding carries into the engagement, making the classic downstream scope creep conversation materially easier to have when it arrives.
Reciprocity. You give scope reduction. They give investment proportionality. The exchange is transparent and fair, which makes it difficult to argue against without explicitly asking for less scope at the same price. That is an ask most buyers will not make aloud, because it exposes the play.
The Win Condition
The buyer selects a scope tier at the corresponding investment level, preserving your margin ratio. Or they determine they need the full scope, in which case the Scope Minimizer is neutralized. Either outcome protects the deal’s economics and establishes the right precedent for everything that follows.
FRACTIONAL CRO
83 percent of the VC, PE, and family office teams that reach out to me share the same situation: a portfolio company that has plateaued on revenue, lost pipeline velocity, or cannot convert at the rate the investment thesis required. The problem is almost always the same place. Sales and marketing are not operating as a system.
I serve as a Fractional CRO and Revenue Architect for growth-stage companies at inflection points. I have sat in a range of C-suite chairs across 15+ organizations, but the engagement that moves the needle fastest is always the one that starts with the revenue engine. If your portco has stalled, let us diagnose it.
Three signals from this week across Venture Capital, Private Equity, Family Offices, and Capital:
Family Office Deal-Making Rebounded in April, Led by Healthcare Bets. Family offices completed 55 direct investments in April, up from 39 in March, according to exclusive Fintrx data reported by CNBC. Nearly one-third of those deals went into healthcare and life sciences, including companies such as Ultralight, Stipple Bio, and Exciva. The signal is not just that family offices are active again; it is that they are still leaning hard into sectors where policy pressure, research funding constraints, and long-duration innovation intersect. For operators in healthcare-adjacent businesses, that matters because this capital is increasingly behaving like strategic capital, not just patient capital. Source: CNBC, cnbc.com
Private equity still sits on roughly $1 trillion in unsold assets, keeping the exit machine under strain. Reuters said the backlog remains large even as firms try to push deals through a slower M&A environment. That combination usually creates a more disciplined buyer pool, longer hold periods, and more emphasis on operational improvement rather than financial engineering alone. For management teams, that means the bar for value creation keeps rising. Source: Reuters, Reuters.com
Wall Street is still betting on a 2026 deal boom, despite geopolitical caution. Reuters reported that banks and dealmakers continue to expect stronger transaction activity ahead, even as uncertainty around global events tempers conviction. The signal here is not that risk has disappeared; it is that capital is still looking for motion, and sponsors are positioning for an active second half. Source: Reuters, Reuters.com
NYU: SCALING SUCCESS STORIES
NYU, here I come. And I need your story.
I recently joined NYU as a faculty member in the Master of Science in Entrepreneurship and Management program, where I am writing and later this year instructing the course “Scaling and Exiting the Business for Maximum Value.” The curriculum is being built around real operator experience, not case studies from a textbook.
If you have led a company through a significant growth inflection, a VC, PE, or family office-backed scale, or a successful exit, I want to hear from you. The operators who built something real are the curriculum.
Every operator knows the downstream version of this problem. The engagement is live. The client wants more. The price does not move. You issue a Change Order or write a new SOW and the economics hold. That discipline exists and it matters.
What gets missed is what happens before any of that.
The Scope Minimizer runs at pre-close, after value has been agreed and pricing is on the table. It does not ask for more work at the same price. It asks for a lower price, dressed up as a scope reduction. The buyer adjusts what they are asking for in order to adjust what they pay, without regard for whether the reduced scope can deliver the outcome they said they needed.
The seller who does not see the move closes the deal, recalculates delivery margin afterward, and finds they have 80 to 90 percent of the original cost base against 14 percent less revenue. And they have set a precedent. The client now knows that scope is negotiable. That knowledge does not stay upstream.
PMI’s research puts scope creep in 52 percent of projects. The operators who build the right precedent at pre-close are not in that number at the same rate. The Scope Trade is not just a pre-close tactic. It is the beginning of a delivery culture.
Scope is currency. Trade it.
SAM SPEAKS
I speak to executive audiences on three topics.
Scaling and Exiting the Business for Maximum Value. Most operators spend years building a company and weeks preparing for the exit. The ones who capture maximum value at the table are the ones who treated the exit as a strategy, not an event. This talk draws on 12+ years of scaling and exiting experience across 15+ organizations, and the curriculum I am currently developing as an NYU faculty member, to give executive audiences a field-level framework for building toward a transaction from day one.
The Unrealistic Leader. The leaders who build enduring organizations are not the ones who set realistic expectations. They are the ones who hold an unrealistic standard long enough for the organization to grow into it. This talk is a practitioner’s case for why the most dangerous thing a leader can do is become reasonable too early, and what it actually looks like to lead from the front when the numbers do not yet support the vision.
The Price Pressure Playbook. Buyers have a playbook. Most sellers do not know it exists. Drawing from my published work cataloguing 20 buyer pressure tactics and the 20 operator moves that counter them, this talk gives revenue leaders and executive teams a tactical framework for protecting margin, closing at full value, and recognizing the moves being run against them in real time.
From the Tip of the Spear is my weekly publication for executives who are building something real. One issue, every Tuesday. A field report from active operator engagements, one principle with supporting data, and market intelligence from across my VC, PE, and family office network.
